← Back to Search

Behavioural Intervention

Intervention Arm for Smoking

N/A
Waitlist Available
Led By Brian P Jenssen, MD, MSHP
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult Intervention Subject Inclusion Criteria
* Males or females ages ≥18 years in age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 and 6 months
Awards & highlights

Summary

The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.

Eligible Conditions
  • Smoking
  • Smoking Cessation
  • Secondhand Smoke

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Combustible tobacco quit rate at 1 and 6 months
The proportion of adult participants who engage in any evidence-based tobacco use treatments

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Adult intervention arm participants will receive motivational counseling provided by the study staff member enrolling them. The study team member will offer 4 evidence-based treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), emphasizing that the combination is often more effective than one treatment alone, and that they could start treatment even if they are not ready to quit.
Group II: Control ArmActive Control1 Intervention
Adult control arm participants will receive a handout listing tobacco treatment options that they can connect to on their own

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,739 Previous Clinical Trials
7,508,535 Total Patients Enrolled
36 Trials studying Smoking
14,215 Patients Enrolled for Smoking
Children's Hospital of PhiladelphiaLead Sponsor
713 Previous Clinical Trials
8,590,017 Total Patients Enrolled
1 Trials studying Smoking
30 Patients Enrolled for Smoking
National Cancer Institute (NCI)NIH
13,751 Previous Clinical Trials
40,960,255 Total Patients Enrolled
65 Trials studying Smoking
54,333 Patients Enrolled for Smoking
~2133 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top